Loading clinical trials...
Loading clinical trials...
Phase I Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Characteristics of JP-2266 after Oral Administration in Healthy Male Caucasian Subjects
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Jeil Pharmaceutical Co., Ltd.
NCT07590193 · Diabetes Mellitus, Type 2
NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more
NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more
NCT03481829 · Diabetes Mellitus, Obesity, and more
NCT07581145 · Foot Ulcer Due to Type 2 Diabetes Mellitus
OPTIMED clinical research
Gières
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions